Antidepressants use in pediatric populations

Expert Opinion on Drug Safety

Volumn 7, Issue 3, 2008, Pages 223-225

  Gören, Jessica L ^a  

^a CAMBRIDGE HEALTH ALLIANCE   (United States)

Author keywords

Adolescent; Antidepressant; Child; Pediatrics; Suicide

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DRUG; FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

CARDIOTOXICITY; CHILD CARE; CLINICAL TRIAL; DRUG INFORMATION; DRUG SAFETY; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR DEPRESSION; MEDICAL EXPERT; MENTAL DISEASE; NEUROPSYCHIATRY; POPULATION RESEARCH; PRESCRIPTION; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; ADOLESCENT; ADULT; ADVISORY COMMITTEE; CHILD; DRUG CONTRAINDICATION; DRUG LABELING; INCIDENCE; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; ADVISORY COMMITTEES; ANTIDEPRESSIVE AGENTS; CHILD; DEPRESSIVE DISORDER, MAJOR; DRUG LABELING; HUMANS; INCIDENCE; SEROTONIN UPTAKE INHIBITORS; SUICIDE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 44949093484     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.7.3.223     Document Type: Editorial

References (14)

1. Hamilton BE, Minino AM, Martin JA, et al. Annual summary of vital statistics: 2005. Pediatrics 2007;119:345-60
2. Gould MS, Greenberg T, Velting DM, Shaffer D. Youth suicide risk and preventive interventions: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 2003;42:386-405
3. Olfson M, Shaffer D, Marcus SC, Grennberg T. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 2003;60:978-92
4. Gibbons RD, Hur K, Bhaumik DK, Man JJ. The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am J Psychiatry 2006;163:1898-904
5. Libby AM, Brent DA, Morrato EH, et al. Decline in treatment of pediatric depression after the FDA advisory risk on suicidality with SSRIs. Am J Psychiatry 2007;164:884-91
6. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressants. Arch Gen Psychiatry 2006;63:332-9
7. Posner K, Oquendo MA, Gould M, et al. Columbia classification algorithm of suicide assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 2007;164:1034-43
8. Kaizar EE, Greenhouse JB, Seltman H, Kelleher K. Do antidepressants cause suicidality in children? A Bayesian meta-analysis. Clin Trial 2006;3:73-90
9. Nemeroff CB, Kalal A, Keller MB, et al. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry 2007;64:466-72
10. Kurian BT, Ray WA, Arbogast PG, et al. Effect of regulatory warning on antidepressant prescribing for children and adolescents. Arch Pediatr Adolesc Med 2007;161:690-6
11. Chen YW, Disalver SC. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other axis I disorders. Biol Psychiatry 1996;39:896-9
12. Harris EC, Barraclough B. Suicide as an outcome for mental disorders: meta-analysis. Biol Psychiatry 1997;170:205-8
13. Kessler RC, Berglund P, Borges C, et al. Trends in suicidal ideation, plans, gestures, and attempts in the United States. JAMA 2005;293:2487-95
14. Baldessarini RJ. Drug therapy of depression and anxiety disorders. In: Brunton LL, Lazo JS, Parker KL, editors, The pharmacologic basis of therapeutics. 11th edition. New York: McGraw Hill Press; 2001. p. 429-59